CLINICAL TRIALS PROFILE FOR AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
✉ Email this page to a colleague
All Clinical Trials for AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05646693 ↗ | Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus | Recruiting | Hospital Civil de Guadalajara | Phase 2 | 2022-12-01 | The main objective of our study is to evaluate the effect of combinated antioxidants therapy with Adepsique® (amitriptyline, perphenazine, and diazepam) on patients with tinnitus chronic symptoms, evaluating the levels of inflammatory cytokines and oxidative stress in blood. The researchers intend to include 58 patients, divided into two intervention groups, who will be randomly assigned a pill with antioxidants or placebo, and the patient must eat one pill per day for 3 months. In the study, the clinical characteristics of tinnitus, inflammatory cytokines and oxidative stress markers will be evaluated, before, during and after the intervention with antioxidant therapy. Subsequently, the clinical and sample results will be evaluated to compare the effects between them. |
| NCT05646693 ↗ | Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus | Recruiting | Institute of Experimental and Clinical Therapeutics | Phase 2 | 2022-12-01 | The main objective of our study is to evaluate the effect of combinated antioxidants therapy with Adepsique® (amitriptyline, perphenazine, and diazepam) on patients with tinnitus chronic symptoms, evaluating the levels of inflammatory cytokines and oxidative stress in blood. The researchers intend to include 58 patients, divided into two intervention groups, who will be randomly assigned a pill with antioxidants or placebo, and the patient must eat one pill per day for 3 months. In the study, the clinical characteristics of tinnitus, inflammatory cytokines and oxidative stress markers will be evaluated, before, during and after the intervention with antioxidant therapy. Subsequently, the clinical and sample results will be evaluated to compare the effects between them. |
| NCT05646693 ↗ | Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus | Recruiting | University of Guadalajara | Phase 2 | 2022-12-01 | The main objective of our study is to evaluate the effect of combinated antioxidants therapy with Adepsique® (amitriptyline, perphenazine, and diazepam) on patients with tinnitus chronic symptoms, evaluating the levels of inflammatory cytokines and oxidative stress in blood. The researchers intend to include 58 patients, divided into two intervention groups, who will be randomly assigned a pill with antioxidants or placebo, and the patient must eat one pill per day for 3 months. In the study, the clinical characteristics of tinnitus, inflammatory cytokines and oxidative stress markers will be evaluated, before, during and after the intervention with antioxidant therapy. Subsequently, the clinical and sample results will be evaluated to compare the effects between them. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
Condition Name
Clinical Trial Locations for AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
Clinical Trial Progress for AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
Clinical Trial Phase
Clinical Trial Sponsors for AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
Sponsor Name
